GRIGIONI, FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 10.635
NA - Nord America 2.551
EU - Europa 1.440
SA - Sud America 711
OC - Oceania 66
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.472
Nazione #
SG - Singapore 7.776
US - Stati Uniti d'America 2.447
CN - Cina 1.267
HK - Hong Kong 958
BR - Brasile 548
IT - Italia 407
GB - Regno Unito 331
VN - Vietnam 329
DE - Germania 182
NL - Olanda 132
IN - India 84
EE - Estonia 73
AU - Australia 66
CA - Canada 65
ID - Indonesia 61
AR - Argentina 59
CZ - Repubblica Ceca 52
FI - Finlandia 39
EC - Ecuador 38
ZA - Sudafrica 32
FR - Francia 31
UA - Ucraina 31
MX - Messico 29
JP - Giappone 27
BD - Bangladesh 25
ES - Italia 22
PL - Polonia 22
RU - Federazione Russa 21
TR - Turchia 19
IR - Iran 18
CL - Cile 16
CO - Colombia 15
PY - Paraguay 15
BE - Belgio 14
SE - Svezia 14
MA - Marocco 10
LT - Lituania 9
PH - Filippine 8
AT - Austria 7
CH - Svizzera 7
MY - Malesia 7
PE - Perù 7
PK - Pakistan 7
RO - Romania 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
TH - Thailandia 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
TW - Taiwan 5
VE - Venezuela 5
AL - Albania 4
GR - Grecia 4
IE - Irlanda 4
IL - Israele 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
EG - Egitto 3
IQ - Iraq 3
KZ - Kazakistan 3
MK - Macedonia 3
NO - Norvegia 3
NP - Nepal 3
PT - Portogallo 3
UY - Uruguay 3
AM - Armenia 2
AZ - Azerbaigian 2
DK - Danimarca 2
DZ - Algeria 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KR - Corea 2
KW - Kuwait 2
LU - Lussemburgo 2
OM - Oman 2
RS - Serbia 2
UZ - Uzbekistan 2
AD - Andorra 1
AO - Angola 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
CU - Cuba 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
IS - Islanda 1
JM - Giamaica 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
NA - Namibia 1
NI - Nicaragua 1
PA - Panama 1
RE - Reunion 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 15.469
Città #
Hong Kong 947
Singapore 846
Ashburn 781
Hefei 613
Dallas 396
Boardman 368
London 271
Shanghai 204
Beijing 174
Ho Chi Minh City 119
Rome 112
Amsterdam 102
Council Bluffs 95
Hanoi 79
Munich 74
Tallinn 68
Los Angeles 67
São Paulo 50
San Francisco 46
Washington 43
Seattle 41
Brno 39
Milan 37
Santa Clara 36
Pune 30
West Jordan 26
Tokyo 24
Montreal 22
Perth 22
Brooklyn 21
Rio de Janeiro 21
Helsinki 20
Melbourne 19
New York 19
Toronto 19
Turku 18
Warsaw 18
Mexico City 17
Boston 15
Chennai 15
Chicago 15
Johannesburg 14
Brasília 13
Jinan 13
Thái Bình 13
Quito 12
Bengaluru 11
Da Nang 11
Haiphong 11
Hanover 11
Frankfurt am Main 10
Guayaquil 10
Jakarta 10
Olomouc 10
Reggio Emilia 10
Santiago 10
Stockholm 10
Sydney 10
Bắc Ninh 9
Porto Alegre 9
Xi'an 9
Zhengzhou 9
Bari 8
Belo Horizonte 8
Biên Hòa 8
Canberra 8
Oxford 8
Salvador 8
Brussels 7
Buenos Aires 7
Campinas 7
Dhaka 7
Hortolândia 7
Hải Dương 7
Manchester 7
Qingdao 7
San Jose 7
Turin 7
Asunción 6
Bocholt 6
Bologna 6
Buffalo 6
Caxias do Sul 6
Fortaleza 6
Madrid 6
Manaus 6
Mauá 6
Phoenix 6
Secaucus 6
Viamão 6
Zhoukou 6
Ankara 5
Atlanta 5
Bogotá 5
Can Tho 5
Denver 5
Duque de Caxias 5
Ha Long 5
Juiz de Fora 5
Kuala Lumpur 5
Totale 6.415
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 412
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 221
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 215
Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence 211
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 204
Characterization of inflammatory profile by breath analysis in chronic coronary syndromes 204
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 203
Current diagnostic ECG criteria for left ventricular hypertrophy: is it time to change paradigm in the analysis of data? 201
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 200
An open international registry to evaluate medical and surgical outcomes of aortic valve insufficiency and ascending aorta aneurysm. 198
Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients 197
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 195
3D transesophageal echocardiographic assessment of acute reverse remodeling of the tricuspid annulus after transcatheter edge-to-edge repair 194
Simultaneous presence of Brugada and overgrowth syndromes 193
A sudden right-to-left shunt: the importance of evaluating patent foramen ovale during exercise 192
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 190
Acute pharmacological tests in patients with primary and precapillary secondary pulmonary hypertension 190
Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention 189
Carcinoid Pulmonary Valve Stenosis: Multimodality Imaging and Transcatheter Valve Implant With Prestenting Technique 189
Assessment of cardiopulmonary capacity in deconditioned athletes because of knee injury 189
Current management and prognosis of patients with recurrent myocardial infarction 187
Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis 187
Accelerated QRS widening as an independent predictor of cardiac death or of the need for heart transplantation in patients with congestive heart failure. 186
Age and heart transplantation: results from a heart failure management unit. 186
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 184
Association of bone biomarkers with advanced atherosclerotic disease in people with overweight/obesity 183
Antithrombotic treatment for valve prostheses: Which drug, which dose, and when? 180
Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma 176
Andamento dei livelli plasmatici dei neurormoni dopo il trapianto cardiaco 176
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 173
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 158
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 144
Cardiovascular and metabolic effects of hyperbilirubinemia in a cohort of Italian Olympic athletes 129
A novel tricuspid flow optimiser for severe tricuspid regurgitation (TRiFlO) 119
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 111
A State-of-the-Art Review on Sleep Apnea Syndrome and Heart Failure 108
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 105
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 103
Non-INvasive Functional and Anatomic vascular evaluation for the prediction of coronary artery disease: The NINFA study 101
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 100
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? 100
Impact of endothelial dysfunction on long-term clinical outcomes in patients with chronic coronary syndromes treated with second generation drug-eluting stent implantation 98
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus 96
Correction to: The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization 95
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 95
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 95
Combined procedure of transcatheter aortic valve replacement and coronary intravascular lithotripsy 93
Aortic Valve Surgery in Nonelderly Patients: Insights Gained From AVIATOR 91
Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment 90
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 88
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention 87
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 86
Breath Analysis via Gas Chromatography-Mass Spectrometry (GC-MS) in Chronic Coronary Syndrome (CCS): A Proof-of-Concept Study 84
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies 82
Invasive Assessment of Coronary Microvascular Function 79
Assessment of mitral regurgitation through Doppler echocardiography: Feasibility, pitfalls and diagnostic advantages 78
The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum 77
Chemoreceptor hyperactivity in heart failure: Is lactate the culprit? 74
Impact of Mediterranean diet on metabolic and inflammatory status of patients with polyvascular atherosclerotic disease 73
The Spectrum of Coronary Artery Disease in Elite Endurance Athletes-A Long-Standing Debate: State-of-the-Art Review 70
Relation of endothelin-1 to survival in patients with primary pulmonary hypertension 70
DOACs vs Vitamin K Antagonists During Cardiac Rhythm Device Surgery: A Multicenter Propensity-Matched Study 69
Relazione comparativa tra capacità funzionale e profilo emodinamico in pazienti con scompenso cardiaco cronico biventricolare o scompenso cardiaco destro puro 65
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19: a systematic review and meta-analysis 61
Valutazione italiana del "Minnesota Living with Heart Failure Questionnaire" 61
Systematic review and meta-analysis of randomized and nonrandomized studies on fractional flow reserve-guided revascularization 60
In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches 50
Evaluation of postural disorders in patients pre and post heart transplant. 46
Eosinophilic Myocarditis: From Bench to Bedside 43
The current paradigm of cardiac troponin increase among athletes 43
Severe heart failure and intracardiac thrombosis: going beyond the appearance for diagnosis and treatments 42
Twenty-Year Outcome after Mitral Repair Versus Replacement for Severe Degenerative Mitral Regurgitation: Analysis of a Large, Prospective, Multicenter, International Registry 42
Extracorporeal membrane oxygenation for the treatment of refractory cardiogenic shock in adults: strategies, results, and predictors of mortality = Sistemi di ossigenazione a membrana extracorporea come trattamento per lo shock cardiogeno refrattario nella popolazione adulta: strategie, risultati e predittori di mortalità 41
Impact of Chronic Kidney Disease and Platelet Reactivity on Clinical Outcomes Following Percutaneous Coronary Intervention 40
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 40
Traditional and Advanced Echocardiographic Evaluation in Chronic Obstructive Pulmonary Disease: The Forgotten Relation 40
Effects of Environmental Conditions on Athlete's Cardiovascular System 40
Cytomegalovirus infectious burden is proportional to cardiac allograft vasculopathy in heart transplant recipients 40
Reappraisal of the Concept and Implications of Pulmonary Hypertension in Degenerative Mitral Regurgitation 39
Malattie valvolari, febbre reumatica 38
Tricuspid regurgitation: what is the real clinical impact and how often should it be treated? 38
Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients. 38
Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy. A Clinical-Pathological Study of 30 Explanted Hearts 38
Impact of Pre-Transplant Pulmonary Hypertension Grading on Early- to Long-Term Hemodynamics, Right Venticular Graft Function and Survival After Heart Transplantation 37
Ruolo residuo della terapia medica e con device nei pazienti affetti da scompenso cardiaco cronico riferiti per trapianto 37
Significato prognostico dei livelli plasmatici di endotelina-1 in pazienti con ipertensione arteriosa polmonare primitiva 37
Factors influencing post-surgical survival in degenerative mitral regurgitation 37
Effects of Finerenone on Cardiovascular and Chronic Kidney Diseases: A New Weapon against Cardiorenal Morbidity and Mortality-A Comprehensive Review 36
QRS interval time-related changes and prognosis in heart failure. 36
Le complicanze metaboliche post-trapianto di cuore ruolo dell'adiponectina ed associazione con la malattia coronarica del graft 36
Mechanical circulatory support with centrifugal pump as bridge to heart transplantation 36
Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches 36
Unusual rapid evolution of type B aortic dissection in a Marfan patient following heart transplantation: successful endovascular treatment. 36
Studio prospettico randomizzato sull'effetto della terapia con acido folico nella preenzione della malattia coronarica nel paziente trapiantato 36
 RELAZIONE TRA PROFILO NEUROORMONALE E SOPRAVVIVENZA IN PAZIENTI CON IPERTENSIONE POLMONARE PRIMITIVA O PRECAPILLARE SECONDARIA 36
The Central Role of Left Atrium in Heart Failure 35
The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization 35
Insufficienza mitralica organica: parametri ecocardiografici, funzionali e neuro-ormonali potenziali predittori di intervento chirurgico a breve termine 35
Correlazione tra metodi semiquantitativi e quantitativi nella valutazione dell'insufficienza mitralica organica ed associazione con test da sforzo cardiopolmonare e pro-BNP 35
The Pilot European Survey of Atrial Fibrillation: How to look at heart failure through a keyhole 35
Totale 10.609
Categoria #
all - tutte 115.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.381


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022331 0 2 7 11 6 9 6 3 15 16 13 243
2022/2023283 10 9 22 18 29 4 10 11 6 7 153 4
2023/20241.461 24 115 82 90 109 459 58 304 64 72 24 60
2024/202510.194 211 100 368 177 83 286 192 61 760 713 3.500 3.743
2025/20263.378 822 376 849 1.295 36 0 0 0 0 0 0 0
Totale 15.647